Form 4: Biogen Director William Hawkins Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director William Hawkins of Biogen Inc. reports acquisition and disposal of common stock on June 21, 2024.
Summary
- On June 21, 2024, William Hawkins, a director at Biogen Inc., reported changes in his beneficial ownership of the company's common stock.
- Hawkins acquired 1,340 shares of common stock.
- Hawkins disposed of 0 shares of common stock.
- Following these transactions, Hawkins beneficially owns 6,490 shares of Biogen Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities.
Stakeholder Impact
- The change in beneficial ownership may have a minor impact on shareholders' perception of the company.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of transaction: Acquisition and disposal of Biogen common stock. |
| 06/25/2024 | Date of signature by Attorney in Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.